Stock Analysis on Net

Procter & Gamble Co. (NYSE:PG)

Cash Flow Statement 
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Procter & Gamble Co., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net earnings 4,659 3,987 3,144 3,781 3,493 4,556 3,392 3,424 3,959 3,963 3,058 3,367 4,242 4,126 2,908 3,249 3,887 4,308 2,786 2,957 3,743 3,617 (5,237) 2,776 3,216 3,211
Depreciation and amortization 706 728 761 712 721 702 706 692 653 663 722 690 684 711 710 683 671 671 814 799 677 723 820 711 650 643
Loss on early extinguishment of debt 512
Share-based compensation expense 136 105 129 158 150 125 139 156 145 105 130 130 152 116 142 144 165 89 233 123 92 110 216 118 79 102
Deferred income taxes 37 184 (38) (52) (256) 102 (93) 38 (268) (130) (143) (158) (158) 57 (91) (312) (48) 193 (8) (39) 37 (586) (387) (61) 3 34
(Gain) loss on sale of assets (7) 794 (164) (48) (3) (36) (1) (2) (1) (1) (2) (9) (73) (1) (1) (2) (12) (4) 24 (11) (2) (308) (9) (361)
Indefinite-lived intangible asset impairment charge 1,341 8,345
Change in accounts receivable (128) (134) (74) 147 (9) (830) (6) 353 86 (740) 222 (272) 368 (1,012) 262 (142) 363 (825) 499 392 4 (261) 273 (151) 77 (475)
Change in inventories 18 (188) (23) (15) 110 (142) 384 152 238 (893) 5 (412) (431) (409) 90 (182) (80) (137) (104) 16 (549) 362 (70) (37) (494)
Change in accounts payable and accrued and other liabilities (509) (648) 1,758 (246) (555) 857 922 (786) (1,318) 1,495 82 (84) 170 1,261 342 737 (130) 442 1,185 (220) (193) 1,151 415 300 208 933
Change in other operating assets and liabilities (190) (558) (218) (492) (33) (671) (268) (304) (81) (454) (504) (47) 94 (178) (277) (78) 16 (30) (652) (3) (20) (35) (436) (167) (286) (84)
Change in operating assets and liabilities (809) (1,528) 1,443 (606) (487) (786) 1,032 (585) (1,075) (592) (195) (815) 201 (338) 417 335 169 (550) 928 169 (193) 306 614 (88) (38) (120)
Other 103 32 479 143 138 208 201 139 162 62 142 34 9 44 36 (11) 70 40 57 31 19 1 88 61 106 58
Operating activities 4,825 4,302 5,754 4,088 5,100 4,904 5,341 3,863 3,574 4,070 3,713 3,246 5,121 4,643 4,121 4,087 5,424 4,739 4,806 4,064 4,364 4,169 4,151 3,517 4,007 3,567
Capital expenditures (925) (993) (783) (797) (817) (925) (734) (730) (708) (890) (692) (747) (626) (1,091) (714) (656) (567) (850) (658) (731) (605) (1,079) (814) (752) (701) (1,080)
Proceeds from asset sales 2 45 269 69 5 3 37 1 3 5 11 2 12 85 2 1 18 21 2 13 9 6 372 4 9 9
Acquisitions, net of cash acquired (6) (21) (51) (638) (74) (2) (1,032) (349) (34) (4) (54) (2) (95) (3,611) (237)
Other investing activity 2 (154) (4) (13) (190) (300) (50) (13) 289 55 (1) 1 3 (45) (10) (3) (3) 6,152 1,091 1,416 458 443
Investing activities (921) (1,108) (518) (762) (1,002) (1,222) (798) (1,380) (490) (832) (682) (1,776) (960) (1,006) (791) (665) (549) (829) (659) (725) (650) 5,079 647 573 (3,845) (865)
Dividends to shareholders (2,441) (2,445) (2,449) (2,285) (2,288) (2,290) (2,289) (2,224) (2,231) (2,255) (2,262) (2,155) (2,171) (2,182) (2,197) (2,011) (2,025) (2,030) (2,028) (1,906) (1,923) (1,932) (1,937) (1,858) (1,850) (1,853)
Additions to short-term debt with original maturities of more than three months 1,815 4,090 567 163 619 2,179 3,390 3,331 7,472 2,975 265 3,399 4,955 1,792 1,437 971 3,760 1,507
Reductions in short-term debt with original maturities of more than three months (571) (166) (1,661) (3,956) (1,906) (3,897) (5,874) (2,995) (265) (3,315) (6,433) (308) (1,422) (3,772) (1,203) (1,773) (829)
Net additions (reductions) in other short-term debt (2,261) (444) (1,474) (1,409) 1,568 2,172 (2,932) 1,372 (3,486) 1,727 1,766 275 (1,636) 512 2,383 269 (1,837) (4,246)
Increases (reductions) in short-term debt (legacy) (675) 3,088 (7) (61) (383) (3,038) 1,182 24
Additions to long-term debt 995 1,599 1,344 254 1,428 2,569 2,249 2,136 1,988 2,429 4,951 (1) 2,368
Reductions in long-term debt (1,408) (70) (1,331) (1,004) (1) (1,877) 433 (1,103) (1,647) (26) (98) (669) (4,195) (25) (913) 12 (1,546) 33 (24) (978)
Treasury stock purchases (2,510) (1,939) (1,516) (987) (1,003) (1,500) (1,351) (2,002) (4,000) (1,250) (1,249) (4,754) (2,750) (3,000) (3,001) (3,008) (2,000) (901) (3,504) (3,000) (1,750) (1,250) (751) (1,252)
Impact of stock options and other 239 745 940 566 88 311 408 424 249 188 205 585 567 648 174 369 208 893 217 701 185 875 734 1,104 1,061 425
Financing activities (5,571) (634) (2,499) (4,269) (6,049) (2,038) (3,893) (1,753) (2,993) (3,507) (4,158) (4,432) (2,858) (3,428) (3,085) (5,275) (6,441) (6,730) (3,399) 5,945 (6,795) (4,118) (3,304) (5,066) 1,032 (2,656)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (260) 115 (84) (119) 108 (157) 12 53 (235) (185) (56) (129) (127) 36 (81) 115 31 40 (170) 56 (65) 7 18 (43) (70)
Change in cash, cash equivalents and restricted cash (1,927) 2,675 2,653 (1,062) (1,843) 1,487 650 742 144 (504) (1,312) (3,018) 1,174 82 281 (1,934) (1,451) (2,789) 788 9,114 (3,025) 5,065 1,501 (958) 1,151 (24)

Based on: 10-Q (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-K (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-Q (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-K (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-K (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-K (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-K (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-K (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30).

Cash flow statement item Description The company
Operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Procter & Gamble Co. operating activities decreased from Q4 2024 to Q1 2025 but then slightly increased from Q1 2025 to Q2 2025.
Investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Procter & Gamble Co. investing activities decreased from Q4 2024 to Q1 2025 but then slightly increased from Q1 2025 to Q2 2025.
Financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Procter & Gamble Co. financing activities increased from Q4 2024 to Q1 2025 but then decreased significantly from Q1 2025 to Q2 2025.